BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2919937)

  • 1. Reassessment of indications for digoxin. Are patients being withdrawn?
    Sueta CA; Carey TS; Burnett CK
    Arch Intern Med; 1989 Mar; 149(3):609-12. PubMed ID: 2919937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment patterns for heart failure in a primary care environment.
    Simko RJ; Stanek EJ
    Am J Manag Care; 1997 Nov; 3(11):1669-76. PubMed ID: 10178465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriateness of digoxin use in medical outpatients.
    Papadakis MA; Massie BM
    Am J Med; 1988 Sep; 85(3):365-8. PubMed ID: 3414732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use of digitalis.
    Aronow WS
    Compr Ther; 1992 Feb; 18(2):38-41. PubMed ID: 1547603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin prescribing for heart failure in elderly residents of long-term care facilities.
    Misiaszek B; Heckman GA; Merali F; Turpie ID; Patterson CJ; Flett N; McKelvie RS
    Can J Cardiol; 2005 Mar; 21(3):281-6. PubMed ID: 15776118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncompliance with congestive heart failure therapy in the elderly.
    Monane M; Bohn RL; Gurwitz JH; Glynn RJ; Avorn J
    Arch Intern Med; 1994 Feb; 154(4):433-7. PubMed ID: 8117176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pattern of the clinical use of digitalis. The need for a reassessment].
    Grossmann G; Mussnich H; Wainstein M; Polanczyk CA; Ribeiro JP
    Arq Bras Cardiol; 1992 Sep; 59(3):195-201. PubMed ID: 1341171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin withdrawal in patients with sinus rhythm.
    Sommers DK; Reitz CJ; Koch Z; Avenant JC
    S Afr Med J; 1981 Aug; 60(6):239-40. PubMed ID: 7256472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin therapeutic drug monitoring: an audit and review.
    Sidwell A; Barclay M; Begg E; Moore G
    N Z Med J; 2003 Dec; 116(1187):U708. PubMed ID: 14752536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure.
    Mathew J; Hunsberger S; Fleg J; Mc Sherry F; Williford W; Yusuf S
    Chest; 2000 Oct; 118(4):914-22. PubMed ID: 11035656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Audit of digoxin prescribing in ambulatory patients.
    Wiser TH; Michocki RJ; Knapp DA; Knapp DA; Ilioff SM
    Hosp Pharm; 1984 Dec; 19(12):811-6. PubMed ID: 10269044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.
    Ghali JK; Giles T; Gonzales M; Horswell R; Kumar S; Lejuene A; Livaudais GF; Sarkar IC
    J La State Med Soc; 1997 Dec; 149(12):474-84. PubMed ID: 9425858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congestive heart failure with sinus rhythm. Audit of digoxin therapy in a family medicine teaching unit.
    Hendry J
    Can Fam Physician; 1993 Dec; 39():2541-5. PubMed ID: 8292929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic heart failure in a managed care setting. Baseline results from the Achieving Cardiac Excellence Project.
    Schmedtje JF; Evans GW; Byerly W; King M; Goonan K; Blastock-Glenn C; Croft JB; Goff DC
    N C Med J; 2003; 64(1):4-10. PubMed ID: 12774552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescribing for chronic heart failure in Europe: does the country make the difference? A European survey.
    Sturm HB; van Gilst WH; Veeger N; Haaijer-Ruskamp FM
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):96-103. PubMed ID: 16528759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Do we use digitalis properly in the management of elderly patients suffering from the signs of chronic heart failure?].
    Erdei F; Vendrey R; Dani G; Kovács E; Márk L; Katona A
    Orv Hetil; 2006 Oct; 147(41):1993-6. PubMed ID: 17120690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between cardiologists and internists in the management of heart failure. Medical guidelines compared with every-day practice.
    Stawicki S; Roik M; Jasik M; Kosior D; Scisło P; Kochanowski J; Dembe K; Steckiewicz R; Karnafel W; Opolski G
    Kardiol Pol; 2004 Nov; 61(11):431-9; discussion 440-1. PubMed ID: 15883591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment of congestive heart failure in Canada: a description of care in five provinces.
    Cox JL; Ramer SA; Lee DS; Humphries K; Pilote L; Svenson L; Tu JV;
    Can J Cardiol; 2005 Mar; 21(4):337-43. PubMed ID: 15838560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin use and digoxin toxicity in the post-DIG trial era.
    Hussain Z; Swindle J; Hauptman PJ
    J Card Fail; 2006 Jun; 12(5):343-6. PubMed ID: 16762795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.